Endothelin-1 stimulates bile acid secretion and vesicular transport in the isolated perfused rat liver. 1994

A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
First Department of Internal Medicine, Nagoya City University Medical School, Japan.

The effects of endothelin (ET) on portal pressure and bile secretion were examined using isolated perfused rat liver and rat hepatocyte preparations. ET-1 raised portal pressure dose dependently; administration at a high dose (10(-9) mol) induced a > 200% increase along with reduced bile flow and decreased secretion of bile acid and phospholipids. However, a low dose (10(-10) mol) of ET-1 brought about a < 100% portal pressure rise, enhanced both bile flow and excretion of bile acid and phospholipids, and significantly increased transfer of preadministered horseradish peroxidase (HRP) into bile. In addition, values for Ca2+ concentrations, examined by indo 1 fluorescence, were elevated in isolated hepatocytes after administration of ET-1. Papaverine suppressed the low-dose ET-1 stimulation effects on both portal pressure and bile secretion. Moreover, it also reduced the HRP excretion and suppressed intracellular Ca2+ release. This study demonstrated that ET-1 stimulates vesicular transport, probably via promotion of intracellular Ca2+ release, and, as a result, increases bile acid-dependent bile flow.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D010208 Papaverine An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. Cerespan,Papaverine Hydrochloride,Pavabid,Pavatym,Hydrochloride, Papaverine
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D006735 Horseradish Peroxidase An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology. Alpha-Peroxidase,Ferrihorseradish Peroxidase,Horseradish Peroxidase II,Horseradish Peroxidase III,Alpha Peroxidase,II, Horseradish Peroxidase,III, Horseradish Peroxidase,Peroxidase II, Horseradish,Peroxidase III, Horseradish,Peroxidase, Ferrihorseradish,Peroxidase, Horseradish
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
May 1992, The American journal of physiology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
May 1997, The American journal of physiology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
August 1985, The Journal of clinical investigation,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
November 1990, The American journal of physiology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
July 1990, Gastroenterology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
February 1995, Hepatology (Baltimore, Md.),
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
September 1994, Hepatology (Baltimore, Md.),
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
October 1975, Canadian journal of physiology and pharmacology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
September 1995, Experimental physiology,
A Tanaka, and K Katagiri, and M Hoshino, and T Hayakawa, and K Tsukada, and T Takeuchi
May 1999, Gastroenterology,
Copied contents to your clipboard!